Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Presenter: Luis Paz-Ares | Author(s): B.P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Marina Chiara Garassino, M. Domine, Pilar Garrido, B. Piperdi, S. Ponce Aix, R. Slepetis, X. Wu, A. Fandi
- Abstract
Loading...
-
+
MS 01 - Clinical Development of Novel Agents
- 11:00 - 12:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:S. Mandrekar, M. Mori
-
+
MS 01.03 - Innovative Trial Designs: What is the Minimal Burden of Proof for Drug Approval?
11:40 - 12:00 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
MA 06 - Lung Cancer Biology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:N. Motoi, Keith M Kerr
-
+
MA 06.05 - Discussant - MA 06.01, MA 06.02, MA 06.03, MA 06.04
16:05 - 16:20 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-050 - Impact of Steroid Use for Immune Related Adverse Events on Outcomes in Non-Small Cell Lung Cancer (NSCLC) Treated with Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Neil J Shah | Author(s): W.J. Kelly, B. Ma, J. Puthiamadathil, M.T. Serzan, Y. Zhou, M. Tan, D. Subramaniam, Giuseppe Giaccone, S.V. Liu
- Abstract
Loading...